New generation anticonvulsants for the treatment of epilepsy in children
- PMID: 16554255
- PMCID: PMC3593448
- DOI: 10.1016/j.nurx.2006.01.013
New generation anticonvulsants for the treatment of epilepsy in children
Abstract
In the last 12 years, 10 new anticonvulsants have been approved by the U.S. Food and Drug Administration and, as a result, the treatment options for children and adults with epilepsy have been expanded considerably. These new generation antiepileptic drugs offer equal efficacy with improved tolerability, pharmacokinetic properties, and side effect profiles compared with the traditional drugs. With many new medications available, the clinician treating children with epilepsy must be well versed in the application of these drugs to their patient population. This manuscript will review the indications, mechanism of action, pharmacokinetics, adverse effects, and dosing of the new generation of anticonvulsant medications.
References
-
- Dodson WE. Pharmacokinetic principles of antiepileptic therapy in children. In: Pellock JM, Dodson WE, Bourgeois BFD, editors. Pediatric epilepsy diagnosis and therapy. Ed 2. New York: Demos Medical Publishing; 2001. pp. 317–327.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
